133 related articles for article (PubMed ID: 10547379)
21. Breast cancer prevention trials using retinoids.
Decensi A; Serrano D; Bonanni B; Cazzaniga M; Guerrieri-Gonzaga A
J Mammary Gland Biol Neoplasia; 2003 Jan; 8(1):19-30. PubMed ID: 14587861
[TBL] [Abstract][Full Text] [Related]
22. Safety of the synthetic retinoid fenretinide: long-term results from a controlled clinical trial for the prevention of contralateral breast cancer.
Camerini T; Mariani L; De Palo G; Marubini E; Di Mauro MG; Decensi A; Costa A; Veronesi U
J Clin Oncol; 2001 Mar; 19(6):1664-70. PubMed ID: 11250995
[TBL] [Abstract][Full Text] [Related]
23. Breast cancer chemoprevention: additional observations.
Singh-Ranger G; Mokbel K
Int J Clin Pract; 2003 Mar; 57(2):155; author reply 155. PubMed ID: 12661805
[No Abstract] [Full Text] [Related]
24. [Results of the NSABP clinical trial for the prevention of cancer of the breast].
Namer M
Bull Cancer; 1998 Apr; 85(4):299. PubMed ID: 9752291
[No Abstract] [Full Text] [Related]
25. Efficacy of vitamin A in the prevention of loco-regional recurrence and second primaries in head and neck cancer.
Jyothirmayi R; Ramadas K; Varghese C; Jacob R; Nair MK; Sankaranarayanan R
Eur J Cancer B Oral Oncol; 1996 Nov; 32B(6):373-6. PubMed ID: 9039219
[TBL] [Abstract][Full Text] [Related]
26. The synthetic retinoid fenretinide lowers plasma insulin-like growth factor I levels in breast cancer patients.
Torrisi R; Pensa F; Orengo MA; Catsafados E; Ponzani P; Boccardo F; Costa A; Decensi A
Cancer Res; 1993 Oct; 53(20):4769-71. PubMed ID: 8402658
[TBL] [Abstract][Full Text] [Related]
27. EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer. For the EUropean Organization for Research and Treatment of Cancer Head and Neck and Lung Cancer Cooperative Groups.
van Zandwijk N; Dalesio O; Pastorino U; de Vries N; van Tinteren H
J Natl Cancer Inst; 2000 Jun; 92(12):977-86. PubMed ID: 10861309
[TBL] [Abstract][Full Text] [Related]
28. Mammographic patterns in breast cancer chemoprevention with fenretinide (4-HPR).
Cassano E; Coopmans de Yoldi G; Ferranti C; Costa A; Mascotti G; De Palo G; Veronesi U
Eur J Cancer; 1993; 29A(15):2161-3. PubMed ID: 8297658
[TBL] [Abstract][Full Text] [Related]
29. Adjuvant treatment of stage I lung cancer with high-dose vitamin A.
Pastorino U; Infante M; Maioli M; Chiesa G; Buyse M; Firket P; Rosmentz N; Clerici M; Soresi E; Valente M
J Clin Oncol; 1993 Jul; 11(7):1216-22. PubMed ID: 8391063
[TBL] [Abstract][Full Text] [Related]
30. A randomized trial on adjuvant treatment of stage I lung cancer with retinol palmitate: preliminary data at three years.
Chiesa G; Soresi E; Pastorino U; Bera E; Clerici M; Infante M; Belloni PA
J Chemother; 1989 Jul; 1(4 Suppl):1203-4. PubMed ID: 16312834
[No Abstract] [Full Text] [Related]
31. Chemoprevention of lung cancer is proving difficult and frustrating, requiring new approaches.
Omenn GS
J Natl Cancer Inst; 2000 Jun; 92(12):959-60. PubMed ID: 10861300
[No Abstract] [Full Text] [Related]
32. Surrogate response biomarkers in prevention research: do they point the way or lead us astray?
Fabian CJ
J Clin Oncol; 2009 Aug; 27(23):3734-6. PubMed ID: 19597020
[No Abstract] [Full Text] [Related]
33. Chemoprevention trial of contralateral breast cancer with fenretinide. Rationale, design, methodology, organization, data management, statistics and accrual.
De Palo G; Camerini T; Marubini E; Costa A; Formelli F; Del Vecchio M; Mariani L; Miceli R; Mascotti G; Magni A; Campa T; Di Mauro MG; Attili A; Maltoni C; Del Turco MR; Decensi A; D'Aiuto G; Veronesi U
Tumori; 1997; 83(6):884-94. PubMed ID: 9526578
[TBL] [Abstract][Full Text] [Related]
34. Fenretinide: a prototype cancer prevention drug.
Malone W; Perloff M; Crowell J; Sigman C; Higley H
Expert Opin Investig Drugs; 2003 Nov; 12(11):1829-42. PubMed ID: 14585058
[TBL] [Abstract][Full Text] [Related]
35. Specific keynote: chemoprevention of ovarian cancer: the journey begins.
Ozols RF; Daly MB; Klein-Szanto A; Hamilton TC; Bast RC; Brewer MA
Gynecol Oncol; 2003 Jan; 88(1 Pt 2):S59-66; discussion S67-70. PubMed ID: 12586088
[No Abstract] [Full Text] [Related]
36. Retinoids as cancer-preventive agents.
Sankaranarayanan R; Mathew B
IARC Sci Publ; 1996; (139):47-59. PubMed ID: 8923019
[TBL] [Abstract][Full Text] [Related]
37. An apple a day...does it really keep the doctor away? The current state of cancer chemoprevention.
Kim ES; Hong WK
J Natl Cancer Inst; 2005 Apr; 97(7):468-70. PubMed ID: 15812064
[No Abstract] [Full Text] [Related]
38. Controlled clinical trials with fenretinide in breast cancer, basal cell carcinoma and oral leukoplakia.
De Palo G; Veronesi U; Marubini E; Camerini T; Chiesa F; Nava M; Formelli F; Del Vecchio M; Costa A; Boracchi P
J Cell Biochem Suppl; 1995; 22():11-7. PubMed ID: 8538187
[TBL] [Abstract][Full Text] [Related]
39. Effect of reduced body weight gain on the evaluation of chemopreventive agents in the methylnitrosourea-induced mammary cancer model.
Rodríguez-Burford C; Lubet RA; Eto I; Juliana MM; Kelloff GJ; Grubbs CJ; Steele VE
Carcinogenesis; 1999 Jan; 20(1):71-6. PubMed ID: 9934852
[TBL] [Abstract][Full Text] [Related]
40. [Breakthrough in breast cancer chemoprevention].
Kahán Z; Thurzó L
Orv Hetil; 2003 Mar; 144(13):597-603. PubMed ID: 12728784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
